US Eye
PrivateLast Round
Growth Equity
Jul 16, 2019
Company Overview
US Eye is a healthcare services company that operates a physician-led, vertically integrated network of ophthalmology, optometry, and multi-specialty eye care practices and surgery centers.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, EHR & EMR, Medical Devices, Revenue Cycle
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
US Eye Comparables
Compare US Eye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| American Vision Partners | 93% | |
| EyeCare Partners | 90% | |
| ReFocus Eye Health | 89% |
US Eye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 16, 2019 |
Key People
Founding team and executive leadership
US Eye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pamlico Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 264% MoM, reaching 15.9K.
- Jul 16, 2025
Grew 537% QoQ, from 138 to 879 employees.
US Eye Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about US Eye's valuation, stock price, and market status.
Is US Eye a public or private company?
US Eye is a private company.
What is the current stock price of US Eye?
US Eye is a private company with no public stock price. Caplight tracks US Eye's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is US Eye worth (valuation)?
Valuation information for US Eye is not publicly available.
Can I buy US Eye stock?
US Eye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was US Eye's last funding round?
US Eye's most recent funding round was Growth Equity on July 16, 2019.
Who are the main investors in US Eye?
Key investors in US Eye include Pamlico Capital.
Will US Eye IPO soon?
No public IPO plans have been announced for US Eye.
How can I track US Eye secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor US Eye's secondary market activity and sign up for updates.